CAP Today recap of FDA panel discussion on whole-slide imaging

CAT Today has a nice recap story on page one about the FDA panel discussion on whole-slide imaging.

Digital pathology recently took center stage in an FDA panel hearing on how best to regulate whole-slide digital imaging systems used for primary pathologic diagnosis. The Hematology and Pathology Devices Panel hearing on Oct. 22 and 23, in fact, tackled a number of issues the lab industry has been grappling with as digital imaging moves into the clinical realm.

The impetus for the panel meeting, surmises Yale pathologist and panel member John Sinard, MD, PhD, is that the FDA realized that the number of whole-slide digital imaging vendors, as well as pathology groups using the technology or looking into it, had reached a “critical mass.”

It's a nice balanced article which tees up many of the interesting issues which were discussed, and quotes many of the participants and Pathology thought leaders.  And me :)